Unidad de Investigación Médica en Inmunología e Infectología, Hospital de Infectología, Centro Médico Nacional La Raza (CMNR), Instituto Mexicano del Seguro Social (IMSS), Mexico City, Mexico.
Asian Pac J Trop Med. 2013 Jul;6(7):505-9. doi: 10.1016/S1995-7645(13)60086-3.
To determine the polymorphisms of Interleukin-10 (IL-10) (-592, -1082) in pulmonary tuberculosis (PTB) with and without type 2 diabetes (T2D).
We studied a Mexican mestizo population of 37 patients with TB in remission (TBr) and 40 with active pulmonary TB (PTB), 21 patients with TB + T2D, 47 blood donors accepted, and 13 healthy health-care workers with tuberculin skin test positive. Determination of IL-10 polymorphisms was performed by real-time Polymerase chain reaction.
IL-10-592C/A presented in a greater proportion in healthy individuals than in patients with type 2 diabetes and TB in a not quite significant statistically manner. IL-10-1082A/A presented more frequently in the group of patients with both diseases, not being statistically significant in comparison with the group of healthy subjects.
This study describes two important new findings. First, it reveals that the IL-10 (-592 A/A and -592 C/C) polymorphisms were found in a greater proportion in a group of patients with T2D and TB than in healthy subjects. Second, the study provides evidence that the (-1082 G/G) polymorphism presented with greater frequency in healthy individuals than in patients with both of these diseases.
确定白细胞介素-10(IL-10)(-592、-1082)在合并 2 型糖尿病(T2D)与不合并 2 型糖尿病的肺结核(PTB)中的多态性。
我们研究了一个墨西哥梅斯蒂索人群,其中包括 37 例缓解期肺结核(TBr)患者和 40 例活动性肺结核(PTB)患者、21 例肺结核+T2D 患者、47 名接受的献血者和 13 名结核菌素皮肤试验阳性的健康医护人员。通过实时聚合酶链反应(PCR)测定 IL-10 多态性。
IL-10-592C/A 在健康个体中的比例大于在合并 T2D 和 TB 的患者中,虽然在统计学上无显著意义。IL-10-1082A/A 在同时患有两种疾病的患者组中更频繁地出现,但与健康对照组相比无统计学意义。
本研究描述了两个重要的新发现。首先,它揭示了 IL-10(-592 A/A 和 -592 C/C)多态性在 T2D 和 TB 患者组中的比例高于健康对照组。其次,研究提供了证据表明,(-1082 G/G)多态性在健康个体中比在同时患有这两种疾病的患者中更频繁出现。